A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
about
Characterizing functional domains for TIM-mediated enveloped virus entryCell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.Synthetic virology: engineering viruses for gene deliveryLibrary screening and receptor-directed targeting of gammaretroviral vectors.DARPins: an efficient targeting domain for lentiviral vectors.Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteinsExpression of a biotin acceptor peptide-containing protein with potential incorporation on the lentiviral envelope as a viral surface engineering platformThe transferrin receptor and the targeted delivery of therapeutic agents against cancer.In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigensNipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivoRole of the phosphatidylserine receptor TIM-1 in enveloped-virus entry.RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?Avidin-biotin technology in targeted therapy.Role of phosphatidylserine receptors in enveloped virus infection.Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.Receptors and tropisms of envelope viruses.Engineered viral nanoparticles for flow cytometry and fluorescence microscopy applications.Streptavidin-biotin technology: improvements and innovations in chemical and biological applications.Lentiviral vector-based therapy in head and neck cancer (Review)Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain.Postexit surface engineering of retroviral/lentiviral vectors.Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.
P2860
Q30409350-F1EEE3BF-700C-4FB4-9D18-A626A5D444BCQ33663063-CFD26735-8DCA-4053-AC55-E44017E9F860Q34487264-A7A300D5-A229-4CEE-9124-E6B7B760F415Q34517833-B94D6B60-20D1-466E-85D3-E35E41DF601FQ34757199-6ECDF904-A634-43A8-9F6B-676275F8D7D8Q35666025-C75CFB8D-C5EA-41AF-872C-D834066E0130Q36216709-19C9E442-89D5-491A-8066-85F9EFE7AF6CQ36406637-2B6465BB-7551-4914-9E3B-BA30CA257B02Q36536212-50AC8C6D-FEE7-4C67-A97C-C09E608F4E97Q36607409-CB0235A5-04CD-4FEE-B385-BD0F0C426D6BQ37036794-85E05904-98D5-455F-BB1C-86835F188F76Q37678411-7219432D-86CF-47A1-A180-4DFF12BFA990Q37710089-31CF11CE-5B4D-4990-85BE-7DA25C74765AQ37713918-AE887B75-9F98-4615-A6B2-A0765E2B3810Q37793233-5B068DB2-4BC3-4C31-B620-BECC5322E6D0Q37909042-C0B61892-918C-412B-8BA5-B0CD114974E5Q38018887-E05F7982-3DF6-4B81-BD70-0E9B16E21110Q38140695-905B0883-29DA-4538-82E4-E633A72385B3Q38172153-8F397B12-3239-4A1B-A8F4-6575BE155BFFQ38847426-E54FD562-F355-4DC6-AD12-D2794DD3058BQ39033552-B0B9DCCA-B4BC-4C64-A7A3-E99E5D08D313Q39372488-29AF0A30-90C9-442B-9D29-8AABE53749B2Q39702309-E5E17DF4-3676-487E-9183-65006C4C8B3FQ39761661-A55711AB-07BB-414E-BE35-101E6076F89FQ41585067-65C991A8-EBFC-465C-807D-959495BDDA3BQ44035393-D7F4E4F6-A1E0-4380-BA22-CBBFFD825631Q50089571-02AC2D54-F459-41E5-B012-1E59384CA94B
P2860
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
@ast
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
@en
type
label
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
@ast
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
@en
prefLabel
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
@ast
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
@en
P2093
P2860
P356
P1476
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide
@en
P2093
Irvin S Y Chen
Kouki Morizono
Manuel L Penichet
Timothy F Lane
Tracy R Daniels
Yiming Xie
P2860
P304
P356
10.1002/JGM.1345
P577
2009-08-01T00:00:00Z